T

TECH

Bio-Techne Corporation
HealthcareBiotechnology|NASDAQ Global Select|US

Price

$53.13

Market Cap

$8.31B

Beta

1.49

P/E

105.5

Div Yield

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+1.64%
EPS Growth (YoY)-48.48%
Revenue CAGR 3Y+2.77%
P/E Ratio105.5
PEG Ratio
FCF Yield+2.68%
Debt / Equity0.17
Interest Coverage12.6x

Sign up free to unlock full analysis

  • Full 24-factor quality scorecard
  • AI investment committee analysis
  • Factor radar & value trap detection
  • 10-year strategy backtesting
  • Advanced screening & filtering
Get started free

No credit card required

Already have an account? Sign in to view the full analysis for TECH.

TECH — Bio-Techne Corporation Stock Analysis | Tessera Alpha